---
document_datetime: 2025-12-02 05:46:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/xigris.html
document_name: xigris.html
version: success
processing_time: 0.1064957
conversion_datetime: 2025-12-28 00:48:59.581334
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Xigris

[RSS](/en/individual-human-medicine.xml/65625)

##### Withdrawn

This medicine's authorisation has been withdrawn

drotrecogin alfa (activated) Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Xigris](#more-information-on-xigris-483)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On the 22 August 2002 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Xigris, drotrecogin alfa (activated), which had been approved for the treatment of adult patients with severe sepsis with multiple organ failure when added to best standard care. The use of Xigris should be considered mainly in situations when therapy can be started within 24 hours after the onset of organ failure. The marketing authorisation holder (MAH) responsible for Xigris was Eli Lilly Nederland B.V.

The European Commission was notified by a letter dated 24 October 2011 of the MAH's decision to voluntarily withdraw the marketing authorisation as of the Commission Decision date for Xigris. On 28 November 2011 the European Commission issued a decision withdrawing the marketing authorisation for Xigris.

Pursuant to this decision the European Public Assessment Report for Xigris is updated to reflect that the marketing authorisation is no longer valid.

Xigris : EPAR - Summary for the public

English (EN) (258.15 KB - PDF)

**First published:** 17/12/2009

**Last updated:** 21/02/2012

[View](/en/documents/overview/xigris-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-911)

български (BG) (445.68 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/bg/documents/overview/xigris-epar-summary-public_bg.pdf)

español (ES) (262.37 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/es/documents/overview/xigris-epar-summary-public_es.pdf)

čeština (CS) (419.59 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/cs/documents/overview/xigris-epar-summary-public_cs.pdf)

dansk (DA) (259.65 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/da/documents/overview/xigris-epar-summary-public_da.pdf)

Deutsch (DE) (261.18 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/de/documents/overview/xigris-epar-summary-public_de.pdf)

eesti keel (ET) (259.16 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/et/documents/overview/xigris-epar-summary-public_et.pdf)

ελληνικά (EL) (437.15 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/el/documents/overview/xigris-epar-summary-public_el.pdf)

français (FR) (261.19 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/fr/documents/overview/xigris-epar-summary-public_fr.pdf)

italiano (IT) (260.09 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/it/documents/overview/xigris-epar-summary-public_it.pdf)

latviešu valoda (LV) (421.35 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/lv/documents/overview/xigris-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (374.52 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/lt/documents/overview/xigris-epar-summary-public_lt.pdf)

magyar (HU) (386.27 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/hu/documents/overview/xigris-epar-summary-public_hu.pdf)

Malti (MT) (398.62 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/mt/documents/overview/xigris-epar-summary-public_mt.pdf)

Nederlands (NL) (260.06 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/nl/documents/overview/xigris-epar-summary-public_nl.pdf)

polski (PL) (402.65 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/pl/documents/overview/xigris-epar-summary-public_pl.pdf)

português (PT) (260.47 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/pt/documents/overview/xigris-epar-summary-public_pt.pdf)

română (RO) (370.48 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/ro/documents/overview/xigris-epar-summary-public_ro.pdf)

slovenčina (SK) (391.41 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/sk/documents/overview/xigris-epar-summary-public_sk.pdf)

slovenščina (SL) (381.58 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/sl/documents/overview/xigris-epar-summary-public_sl.pdf)

Suomi (FI) (259.87 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/fi/documents/overview/xigris-epar-summary-public_fi.pdf)

svenska (SV) (259.92 KB - PDF)

**First published:**

17/12/2009

**Last updated:**

21/02/2012

[View](/sv/documents/overview/xigris-epar-summary-public_sv.pdf)

## Product information

Xigris : EPAR - Product Information

English (EN) (640.98 KB - PDF)

**First published:** 21/12/2009

**Last updated:** 21/02/2012

[View](/en/documents/product-information/xigris-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-897)

български (BG) (1.78 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/bg/documents/product-information/xigris-epar-product-information_bg.pdf)

español (ES) (654.25 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/es/documents/product-information/xigris-epar-product-information_es.pdf)

čeština (CS) (1.29 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/cs/documents/product-information/xigris-epar-product-information_cs.pdf)

dansk (DA) (649.86 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/da/documents/product-information/xigris-epar-product-information_da.pdf)

Deutsch (DE) (1.19 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/de/documents/product-information/xigris-epar-product-information_de.pdf)

eesti keel (ET) (675.47 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/et/documents/product-information/xigris-epar-product-information_et.pdf)

ελληνικά (EL) (1.83 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/el/documents/product-information/xigris-epar-product-information_el.pdf)

français (FR) (669.6 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/fr/documents/product-information/xigris-epar-product-information_fr.pdf)

italiano (IT) (697.01 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/it/documents/product-information/xigris-epar-product-information_it.pdf)

latviešu valoda (LV) (1.33 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/lv/documents/product-information/xigris-epar-product-information_lv.pdf)

lietuvių kalba (LT) (789.88 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/lt/documents/product-information/xigris-epar-product-information_lt.pdf)

magyar (HU) (1.16 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/hu/documents/product-information/xigris-epar-product-information_hu.pdf)

Malti (MT) (1.24 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/mt/documents/product-information/xigris-epar-product-information_mt.pdf)

Nederlands (NL) (699.76 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/nl/documents/product-information/xigris-epar-product-information_nl.pdf)

polski (PL) (1.31 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/pl/documents/product-information/xigris-epar-product-information_pl.pdf)

português (PT) (693.83 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/pt/documents/product-information/xigris-epar-product-information_pt.pdf)

română (RO) (786.76 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/ro/documents/product-information/xigris-epar-product-information_ro.pdf)

slovenčina (SK) (1.32 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/sk/documents/product-information/xigris-epar-product-information_sk.pdf)

slovenščina (SL) (1.14 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/sl/documents/product-information/xigris-epar-product-information_sl.pdf)

Suomi (FI) (645.52 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/fi/documents/product-information/xigris-epar-product-information_fi.pdf)

svenska (SV) (649.69 KB - PDF)

**First published:**

21/12/2009

**Last updated:**

21/02/2012

[View](/sv/documents/product-information/xigris-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** S/0029 28/11/2011

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Xigris : EPAR - All Authorised presentations

English (EN) (270.81 KB - PDF)

**First published:** 11/04/2008

**Last updated:** 21/02/2012

[View](/en/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_en.pdf)

[Other languages (18)](#file-language-dropdown-454)

español (ES) (269.93 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/es/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_es.pdf)

čeština (CS) (300.52 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/cs/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (273.3 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/da/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (275.69 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/de/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (271.57 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/et/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (303.47 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/el/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_el.pdf)

français (FR) (269.47 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/fr/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (269.2 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/it/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (302.94 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/lv/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (292.17 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/lt/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (292.14 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/hu/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (271.43 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/nl/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_nl.pdf)

polski (PL) (304.5 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/pl/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_pl.pdf)

português (PT) (270.81 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/pt/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_pt.pdf)

slovenčina (SK) (302.16 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/sk/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (288.5 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/sl/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (268.35 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/fi/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (271.6 KB - PDF)

**First published:**

11/04/2008

**Last updated:**

21/02/2012

[View](/sv/documents/all-authorised-presentations/xigris-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Xigris Active substance drotrecogin alfa (activated) International non-proprietary name (INN) or common name drotrecogin alfa (activated) Therapeutic area (MeSH)

- Sepsis
- Multiple Organ Failure

Anatomical therapeutic chemical (ATC) code B01AD10

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Xigris is indicated for the treatment of adult patients with severe sepsis with multiple organ failure when added to best standard care. The use of Xigris should be considered mainly in situations when therapy can be started within 24 hours after the onset of organ failure (for further information see section 5.1).

## Authorisation details

EMA product number EMEA/H/C/000396

Exceptional circumstances

This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see [Pre-authorisation guidance](/node/68554) .

Marketing authorisation holder

Eli Lilly Nederland B.V.

Eli Lilly Nederland BV

Marketing authorisation issued 22/08/2002 Withdrawal of marketing authorisation 28/11/2011 Revision 13

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Xigris : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (413.41 KB - PDF)

**First published:** 21/12/2009

**Last updated:** 21/02/2012

[View](/en/documents/procedural-steps-after/xigris-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Xigris-H-C-396-S-29 : EPAR - Assessment Report - Variation

Adopted

English (EN) (572.63 KB - PDF)

**First published:** 23/06/2010

**Last updated:** 21/02/2012

[View](/en/documents/variation-report/xigris-h-c-396-s-29-epar-assessment-report-variation_en.pdf)

Xigris-H-C-396-S-28 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/CHMP/729233/2009

English (EN) (784.9 KB - PDF)

**First published:** 21/12/2009

**Last updated:** 21/02/2012

[View](/en/documents/variation-report/xigris-h-c-396-s-28-epar-assessment-report-variation_en.pdf)

Xigris-H-C-396-II-20 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (443.52 KB - PDF)

**First published:** 30/05/2007

**Last updated:** 21/02/2012

[View](/en/documents/scientific-discussion-variation/xigris-h-c-396-ii-20-epar-scientific-discussion-variation_en.pdf)

Xigris-H-C-396-S-21 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (360.5 KB - PDF)

**First published:** 30/05/2007

**Last updated:** 21/02/2012

[View](/en/documents/scientific-discussion-variation/xigris-h-c-396-s-21-epar-scientific-discussion-variation_en.pdf)

Xigris-H-C-396-S-13 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (585.87 KB - PDF)

**First published:** 17/11/2005

**Last updated:** 21/02/2012

[View](/en/documents/scientific-discussion-variation/xigris-h-c-396-s-13-epar-scientific-discussion-variation_en.pdf)

Xigris : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (305.04 KB - PDF)

**First published:** 17/11/2005

**Last updated:** 21/02/2012

[View](/en/documents/steps-after-cutoff/xigris-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Xigris : EPAR - Procedural steps taken before authorisation

English (EN) (306.63 KB - PDF)

**First published:** 17/11/2005

**Last updated:** 21/02/2012

[View](/en/documents/procedural-steps/xigris-epar-procedural-steps-taken-authorisation_en.pdf)

Xigris : EPAR - Scientific Discussion

English (EN) (858.39 KB - PDF)

**First published:** 17/11/2005

**Last updated:** 21/02/2012

[View](/en/documents/scientific-discussion/xigris-epar-scientific-discussion_en.pdf)

#### More information on Xigris

- [Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy](/en/news/xigris-drotrecogin-alfa-activated-be-withdrawn-due-lack-efficacy) (25/10/2011)

**This page was last updated on** 21/02/2012

## Share this page

[Back to top](#main-content)